The pharmaceutical industry lags in the sophistication and performance of its supply chains when they are compared with best-in-class companies in other industries.
Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials.
The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines.
Collaborating with pharmaceutical / biotech clients worldwide, Vetter supports aseptic products from preclinical development through to global market supply.
Through its US and European facilities, Vetter’s Development Service provides state-of-the-art support for early-stage aspectic products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production.
Vetter Pharma International
The company offers state-of-the-art technology and innovative processes to promote product quality and maximize active pharmaceutical ingredients (API) yield.
Vetter development service for aseptic products
Vetter Development Service aids clients in the development of drugs, from preclinical to Phase III.
From the outset, the aseptic product is developed with commercial production in mind by using Vetter’s manufacturing techniques. This enables the product to be easily taken to large-scale production by Vetter Commercial Manufacturing.
Growing demand in the US for early-stage support has led to the establishment of the company’s first US facility, based in Chicago.
Vetter Development Service provides:
- Formulation support for aseptic products
- Process development
- Clinical trial manufacturing
- Analytical service
- Regulatory support
Vetter commercial manufacturing
Vetter Commercial Manufacturing offers Phase III clinical manufacturing services to companies worldwide. This service includes:
- Fill and finish
- Analytical support
- Regulatory support
- Product life cycle management
Supply chain security and integrity is maintained through regular quality reviews of upstream and downstream suppliers, as well as cross-linked information technology (IT) systems to enable monitoring.
Vetter provides commercial manufacturing services for the global top ten biotechnology and pharmaceutical companies.
Vetter packaging solutions
Vetter Packaging Solutions works with clients to find the best packaging solutions for their aseptic drug products.
This can include a drug delivery system (primary packaging), cartoning / blister packaging (secondary packaging) and services such as pen-system assembly.
Vetter Packaging Solutions offers:
- Customised packaging development
- Specialised technologies
- Proven platform technologies
- Packaging services
See how PEARLITOL® Flash allows the production of robust orodispersible tablets even at high dilution.
Whether your injectable is still at the starting line or in full-scale production, there are possibilities all around you. Thoughtful questions that can open new doors.
Vetter is a leading contract development manufacturing organisation that specialises in the aseptic filling of liquid and lyophilised drugs for international biotechnology and pharmaceutical companies.
How can digital trends be used purposefully in regards to the application of injection systems? That is the key question being addressed by Vetter’s Open Innovation Challenge.
Illinois Governor Bruce Rauner has visited Vetter’s facility in Ravensburg, Germany, accompanied by a delegation of approximately twenty key state and county representatives, including notable Illinois economic institutions and organisations.
Vetter has won the 2018 ISPE Facility of the Year Award (FOYA) in the Facility of the Future category for its Center for Visual Inspection and Logistics.
Prefilled drug-delivery systems provider is recognised for its management of occupational health.
International contract development and manufacturing organisation (CDMO) specialising in aseptic filling Vetter has announced that its new clinical syringe line has manufactured a double digit number of batches for use in early clinical trials.
Vetter has announced that its new data processing centre in Ravensberg has been certified by IT experts at German industrial testing organisation TÜV Süd.
The World Packaging Organization (WPO) has awarded Vetter the WorldStar award 2016 for its syringe closure system Vetter-Ject.
Vetter has announced that following two years of construction, its Schuetzenstrasse multi-functional building has been completed on schedule and departments critical to its operation have started to move in.
Vetter has received the status of Authorised Economic Operator Full (AEO-F) from the European Union confirming its reliability, solvency and high safety standards in international trade.
Vetter has announced the opening of a new business entity in Tokyo, Japan.
Vetter has announced the manufacture of the first commercial batches with single-use identification numbers.
Vetter has announced that the company's advisory board unanimously appointed Oliver Albrecht as the new managing director from 1 April 2015.
Following 16 months of construction, the first phase of a modern, multi-functional building at Vetter's Ravensburg Schuetzenstrasse site has been completed.
Vetter has announced its US early-stage development site located at the Illinois Science and Technology Park in Chicago, has completed the next step of its expansion with the addition of a third cleanroom.
Vetter has announced a major milestone concerning drug safety, by offering the option of clearly identifying packaging used for drugs.
Vetter has announced the opening of a new office in Singapore.
Vetter has announced plans to invest more than $100m across its production sites in Germany and the US.
Vetter, a leading contract development and manufacturing organization (CDMO), announced today that its new award-winning filling line at the company's Ravensburg Vetter South facility is fully validated and ready for cGMP filling, after successful media-fill completion.
Vetter, a leading contract development and manufacturing organisation (CDMO), announced today that its new center for visual inspection and logistics passed its first GMP inspection by the US Food and Drug Administration (FDA).
Vetter has announced that it has now been approved as a 'Known Consignor' by the German Federal Aviation Office. The agency officially granted the pharmaceutical service provider the certificate of approval following an audit at Vetter´s Holbeinstrasse and Ravensburg Vetter West facilities.
Vetter has been awarded first place for the category Most Improved Manufacturing Project or Process at this year's European Outsourcing Awards. The application for the company's new high-speed filling line for pre-sterilised syringes was the top choice among the jury of experts due to its intelligent concepts and systems.
The demand for prefilled syringes is on the rise and Vetter is prepared. The company, a leading contract development and manufacturing organisation is building a state-of-the-art, high-performance filling line for syringes at its Ravensburg Vetter South location.
The pharma and biotech industries are increasingly seeking safer and more efficient supply chain processes.
As part of its business growth strategy, Vetter, a leading contract development and manufacturing organisation (CDMO), has announced that a triple-digit million euro syndicated loan has been arranged with a consortium of renowned banks.
Vetter, an international specialist in aseptic filling, will present on best practices in sterile manufacturing and packaging at Pharma Congress 2012 in Dusseldorf, Germany, April 24 and 25. Company experts will address four topic areas, including RABS technology, glass monitoring in aseptic filling, and new developments in drug-delivery systems.
Vetter, a leading contract development and manufacturing organisation that specialises in aseptic filling, has announced that its first US facility is now fully operational.
Vetter Receives Internationally Recognised Certification for Environmental, Health and Safety Programme
Vetter has received certification for its integrated management system for environmental, health and safety (EHS). The company earned ISO 14001 certification for its environmental management system and BS OHSAS 18001 certification for its occupational health and safety management system. These
Vetter Wins Frost & Sullivan 2011 European Prefilled Injection Systems Customer Service Leadership Award
Leading contract development and manufacturing organisation (CDMO) Vetter has received the Frost & Sullivan 2011 European Prefilled Injection Systems Customer Service Leadership Award. The international consulting company recognised Vetter for best practices in its collaboration with global c
Structural work on Vetter's new German facility Ravensburg Vetter West has been completed within eleven months of groundbreaking. As scheduled, the company concluded structural work on its centre for visual inspection and state-of-the-art high-bay warehouse for cold-storage and room-temperature p
Dirk Niebel, Germany's Federal Minister for Economic Cooperation and Development, stopped today at Vetter's Ravensburg Vetter South facility during a regional tour. Vetter is an independent international specialist in the aseptic filling of drug-delivery systems. "Innovative, mid-siz
In keeping with its strategy of US growth and expansion, Vetter, a specialist in aseptically prefilled drug-delivery systems, has announced that it has opened a new sales office at the Illinois Science + Technology Park in Skokie. The office will be managed by Mr Troy Carpenter, who was appointe
A groundbreaking ceremony was held recently for Vetter's newest facility, Ravensburg Vetter West. Vetter, a specialist in aseptically pre-filled drug-delivery systems, will build a state-of-the-art high bay warehouse for cold-storage and room-temperature goods. Space will also be dedicated for au
Vetter has won the silver SAP Quality Award for Europe, the Middle East and Africa (EMEA) for its company-wide implementation of the mySAP ERP planning software. A specialist in the aseptic filling of drug-delivery systems, Vetter captured the prize in the small and medium-sized enterprise cat
Vetter Development Service Chicago is Vetter's first US manufacturing facility and will provide high-quality aseptic filling for early-stage biopharmaceutical products, preclinical through phase II. The facility will be operational at the beginning of Q4 2010. Vetter is an independent i
Vetter’s Participation at the BIO International Convention’s Illinois Pavilion Represents Growth of Midwest Biotech
On 4 May, Illinois Governor Pat Quinn cut the ribbon at the 2010 BIO International Convention. Vetter, a leading provider of aseptic pre-filled drug-delivery systems, was present as the governor toured the Illinois Pavilion. The company represents the burgeoning of the Midwest as the new hotspot
Vetter, a leading provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, have announced that they have signed a preferred partnership agreement. Vetter will fill early-stage, high-value biopharmac
Vetter, a leading provider of aseptic pre-filled drug-delivery systems, announced today that cleanroom infrastructure will be completed by early May at its new Chicago facility, an expansion of Vetter Development Service (VDS), and the site remains on schedule for launch of operations at the begi
Vetter, a leading provider of aseptic pre-filled injection systems, has been awarded the 2009 Axia Award for best customer relationship management. The prize was announced on 4 February. Conferred yearly by the global auditing and consulting firm Deloitte, the award is given to medium-sized compa
Vetter has released its latest white paper, which is called Finding the Right Contract Manufacturer. The company is an independent international specialist in the production of aseptically pre-filled injection systems, cartridges and vials. For more than 25 years Vetter has been renowne
With development times measured in years, increasing costs represent a major challenge confronting pharmaceutical and biotechnology companies. As a result, reducing time-to-market is an essential component in any business strategy, particularly when the end of patent protection is considered. One
The 14th Drug Delivery Partnerships 2010 offers the perfect chance to meet the Vetter team. Please join us 25-27 January in Orlando, US, at the Omni Orlando Resort at Champion's Gate (booth 19). You will have an opportunity to learn about our products and services and speak with one of our repres
Developing drugs is a slow and expensive process, especially for hard-to-treat diseases such as cancer. Biopharmaceutical companies are continuously seeking ways to accelerate development and control costs. With the dedication today of its new 24,000ft² facility at the Illinois Science + T
Vetter, an independent international specialist in the production of aseptically pre-filled injection systems, cartridges and vials, will be attending the BiotechForum/ScanLab 2009 exhibition between 25 and 27 November 2009 in Stockholm, Sweden. At our booth (B02:20) you will have an opportuni
The 2009 AAPS Annual Meeting and Exposition event will take place 8-12 November in Los Angeles, California, US. Visit Vetter at booth 839 to find out more about the company's aseptically pre-filled injection systems, cartridges and vials.
The comprehensive Ravensburg Vetter South site was officially inaugurated on 25 September. The past six years have seen Vetter invest significantly in the site, with a total area of some 80,000m² (862,000ft²), that now includes state-of-the-art facilities for the aseptic filling and pac
Vetter, a Leading International Provider of Aseptically Pre-filled Injection Systems, Opens Technologically Advanced Service Facility in the US
Vetter, one of the world’s leading providers of aseptically pre-filled injection systems, will open Vetter Development Service (VDS), a technologically advanced customer service facility located in Chicago, US, allowing the company to provide greater commitment and support toward the product n
Vetter, one of the world's leading providers of aseptically pre-filled injection systems, has completed the installation of six automatic packaging lines at the company's new packaging services facility, Vetter Secondary Packaging (VSP). The Ravensburg-based packaging facility allows V
With a new state-of-the-art project management program, Vetter will help pharmaceutical and biotech companies to better control the quality and costs of their pre-filled injectable product manufacturing processes. As a specialist in the aseptic filling of syringes, cartridges and vials, Vetter ha
Vetter Pharma-Fertigung (VPF) today announced the formation of a new subsidiary, Vetter Pharma International (VPI). With a scheduled launch date of 1 April 2009, VPI will be responsible for all Vetter sales, marketing and customer service activities on a worldwide level. Peter Soelkner
Ravensburg – This year’s first place prize at the annual TrackWise® Innovation Awards went to Vetter Pharma-Fertigung for its outstanding implementation of Sparta Systems' software solution. Vetter uses TrackWise as part of its broad-based quality management system. A tool is
Outsourcing processes in drug manufacturing is an effective strategy, especially in challenging times, but finding the right partner is a complex issue. Representatives from the manufacturing and supplying segments of the pharmaceutical industry will therefore be meeting in London on December 1 a
Vetter Pharma-Fertigung & Co. KG will inject the International Contract Service Expo (ICSE) with a calibrated dose of knowledge and leadership in the field of aseptically pre-filled product solutions. One of the world’s leading providers of aseptically pre-filled injection systems,
Vetter’s top management team is being strengthened. As of June 1, 2008, Peter Soelkner will be heading a number of divisions at the Ravensburg-based company, which specializes in the filling of prefilled injection systems. His new tasks will include Global Key Account Management, Corporate Market
Vetter Pharma-Fertigung GmbH has been granted approval by the Food and Drug Administration for the production of a new client drug. Vetter, which provides contract manufacturing services for pharmaceutical and biotech companies, will now begin filling an innovative drug at its Ravensburg Vetter S
Japan's Ministry for Health, Labor and Welfare has given Vetter Pharma-Fertigung the go-ahead as a foreign manufacturer for the Japanese pharmaceutical market. Vetter, a world leader in aseptic filling of pre-filled injection systems, received certification in categories including 'drug, sterile
Vetter Pharma Fertigung of Ravensburg, Germany, has started the construction of a new facility for visual inspection and secondary packaging. Vetter, the leading manufacturer of aseptic pre-filled application systems, will be adding the new building close to Ravensburg Vetter South (RVS), its exi
Vetter Pharma-Fertigung GmbH & Co. KG, world leader in the production of aseptically pre-filled injection systems, has won this year's European Outsourcing Award in the Most improved Process/Plant/Facility category. The prize recognized the outstanding new Ravensburg Vetter South facil
Vetter Pharma-Fertigung announce the launch of a new closure system for pre-filled syringes that will enable a greater degree of safety for users. The Vetter V-OVS NS® was designed for syringes with a staked needle. It features mechanisms to prevent tampering, counterfeiting. The closure sys
Vetter Pharma-Fertigung, world leader in the production of aseptically prefilled injection systems, has won this year's Facility of the Year award in the Process Innovation category for its new facility, Ravensburg Vetter South (RVS). The award, which is sponsored jointly by ISPE, INTERPHEX and t
Ravensburg, Germany – Vetter Pharma-Fertigung, the leading expert for aseptic filling of liquid and lyophilized drugs, has received a manufacturing licence according to German drug law from the Tuebingen regional board for its new state-of-the-art plant, Ravensburg Vetter South.
Ravensburg, 27th October 2006 - To round off its full-service capabilities, Vetter Pharma-Fertigung is expanding its services by adding vials for lyophilized substances to its portfolio. Filling will take place at the company's new state-of-the-art facility at Ravensburg Vetter South (RVS), which
Ravensburg, May 4th, 2006 - Vetter Pharma-Fertigung GmbH & Co. KG, a specialist in the production of aseptically pre-filled application systems, has purchased a new property with direct connection to the existing Ravensburg Vetter South production plant. The company plans to build a new f
Ravensburg/Germany, March 06, 2006 - Vetter Pharma-Fertigung GmbH & Co. KG, the leading expert for aseptic filling of liquid and lyophilized drugs, is further expanding its services and facilities. The company, which is based in Ravensburg, Germany, broadened its portfolio of services and
Vetter Pharma-Fertigung has met all of the requested requirements regarding global industry standards for cutting-edge performance in supply chain management. At the end of November 2005, Vetter Pharma-Fertigung GmbH & Co. KG, the leading specialist for the production of asepticall
Ravensburg/Germany, 4th October 2005 - Vetter Pharma-Fertigung GmbH & Co. KG, the leading expert for aseptic filling of liquid and lyophilized drugs, will be enlarging its product portfolio. In the coming months, the company will be expanding the Vetter Development Service (VDS) area to o
Leading specialist in pre-filled syringes to deliver key conference presentation Ravensburg, September 19, 2005 - This year's annual PDA Conference will be staged in Munich, Germany, under the title "The Universe of Pre-filled Syringes." As a gold sponsor of the PDA event an
Vetter Pharma-Fertigung expands its production capacity and continues to strengthen its position as a leading service provider for the pharmaceutical industry. New bio-pharmaceutical production facility Ravensburg Vetter South (RVS) Ravensburg/Germany, June 19,
Vetter - a strategic partner in the early stages of product development One of the greatest challenges in the pharmaceutical industry today is to closely match a product's active substance with its mode of administration. Excellence in the design of application systems and correspondi
Vetter pre-filled systems excel in the marketplace thanks to their high quality, efficient production processes and patient friendly designs. This know-how is passed on to Vetter partners, offering them a competitive edge in markets throughout the world. There is the Vetter Lyo-Ject® double chamber
Vetter has been producing sterile liquid and lyophilized drugs for over 25 years. The company's focus is on aseptically pre-filled injection systems. Vetter is experienced in using a large array of standard injection systems, cartridge systems and its own patented dual-chamber application systems. P